RSM01, a novel respiratory syncytial virus monoclonal antibody: preclinical characterization and results of a first-in-human, randomised clinical trial
RSM01, a novel respiratory syncytial virus monoclonal antibody: preclinical characterization and results of a first-in-human, randomised clinical trial
Adriana Badarau, Joleen T. White, Aurelio Bonavia, Harald Rouha et al.
Citations
5 citations
Journal
BMC Infectious Diseases
Topics
Respiratory viral infections research
Field-Weighted Citation Impact (FWCI)
1.93
article
RSM01, a novel respiratory syncytial virus monoclonal antibody: preclinical characterization and results of a first-in-human, randomised clinical trial
Adriana Badarau, Joleen T. White, Aurelio Bonavia, Harald Rouha, Michael Shaffer, Jonne Terstappen, Aparna Anderson, Shayne Watson, Michael W. Dunne, Luisa M. Stamm, Micha Levi, Jintanat Ananworanich, Andrijana Radivojevic, Dale R. Taylor
article en
5 citations
Abstract
No abstract available for this paper.
Publication Tag
BMC Infectious DiseasesVol. 24(1)
Institutions
Pharmaceutical Product Development (United States) (US), Gates Foundation (US), University Medical Center Utrecht (NL)
Funders
Bill and Melinda Gates Foundation, Universitair Medisch Centrum Utrecht